Flatrock Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
9,150
-484
-5% -$27.8K 0.21% 69
2026
Q1
$584K Buy
9,634
+986
+11% +$57.5K 0.26% 56
2025
Q4
$466K Buy
+8,648
New +$416K 0.22% 67

Other funds holding BMY

Flatrock Wealth Partners's BMY Position: Q2 2026 in Review

Flatrock Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, selling an estimated $27.8K and leaving 9,150 shares worth $527K. The position accounts for 0.21% of the portfolio, ranked #69.

Flatrock Wealth Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $584K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Flatrock Wealth Partners held 9,150 shares of Bristol-Myers Squibb worth $527K as of Q2 2026.
  • Flatrock Wealth Partners sold 484 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.8K.
  • Bristol-Myers Squibb made up 0.21% of Flatrock Wealth Partners's portfolio in Q2 2026, its #69 holding.
  • Flatrock Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Flatrock Wealth Partners's Bristol-Myers Squibb position peaked at $584K in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Flatrock Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.